Company intelligence / Profile preview

KimiKa

Chuo-ku, Tokyo, Japan

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Kimika Corporation is a global leader in the production of alginic acid and its derivatives, derived from natural seaweed sources. The company specializes in high-purity, pharmaceutical-grade alginates used extensively as excipients in drug delivery systems, wound dressings, and gastrointestinal treatments like reflux suppressants. Beyond healthcare, Kimika provides specialized biopolymers for the food, cosmetic, and industrial sectors. Headquartered in Japan with significant operations in Chile, the company is recognized for its sustainable harvesting practices and its role as a critical supplier to the global pharmaceutical industry.

Therapeutic areas: OtherDermatologyGastroenterology
Modalities: BiologicSmall moleculeDrug delivery system
Industry: Chemicals & Materials

Partnerships

Reckitt BenckiserGlaxoSmithKline

Beyond the preview

Go deeper on KimiKa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KimiKa.

Explore the full profile